TY - JOUR
T1 - Tryptophan catabolism and T cell responses
AU - Mellor, Andrew L.
AU - Munn, David
AU - Chandler, Phillip
AU - Keskin, Denn
AU - Johnson, Theodore
AU - Marshall, Brendan
AU - Jhaver, Kanchan
AU - Baban, Babak
PY - 2003/1/1
Y1 - 2003/1/1
N2 - Cells expressing indoleamine 2,3 dioxygenase (IDO) play key roles in regulating adaptive immune responses orchestrated by T cells. In this report we discuss our working model, the tryptophan depletion hypothesis, to explain links between IDO expression and inhibition of T cell responses. We posit that IDO+ cells, particularly professional antigen presenting cells (APCs) promote T cell entry but block cell cycle progression due to tryptophan catabolism. We discuss experimental evidence supporting predictions from the tryptophan depletion hypothesis and the implications that this model has for understanding the origin of tolerant states that explain immunological paradoxes, such as fetal survival, tumor persistence and failure to eradicate pathogens like HIV that cause persistent infections.
AB - Cells expressing indoleamine 2,3 dioxygenase (IDO) play key roles in regulating adaptive immune responses orchestrated by T cells. In this report we discuss our working model, the tryptophan depletion hypothesis, to explain links between IDO expression and inhibition of T cell responses. We posit that IDO+ cells, particularly professional antigen presenting cells (APCs) promote T cell entry but block cell cycle progression due to tryptophan catabolism. We discuss experimental evidence supporting predictions from the tryptophan depletion hypothesis and the implications that this model has for understanding the origin of tolerant states that explain immunological paradoxes, such as fetal survival, tumor persistence and failure to eradicate pathogens like HIV that cause persistent infections.
UR - http://www.scopus.com/inward/record.url?scp=1042268021&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=1042268021&partnerID=8YFLogxK
U2 - 10.1007/978-1-4615-0135-0_3
DO - 10.1007/978-1-4615-0135-0_3
M3 - Article
C2 - 15206713
AN - SCOPUS:1042268021
SN - 0065-2598
VL - 527
SP - 27
EP - 35
JO - Advances in experimental medicine and biology
JF - Advances in experimental medicine and biology
ER -